Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
about
Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-κB signaling.Inhibitory effect of black tea pigments, theaflavin‑3/3'-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest.Inhibitory Effects of Total Triterpenoid Saponins Isolated from the Seeds of the Tea Plant (Camellia sinensis) on Human Ovarian Cancer Cells.Verrucarin J inhibits ovarian cancer and targets cancer stem cells.Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer.Theaflavin-3,3'-Digallate Enhances the Inhibitory Effect of Cisplatin by Regulating the Copper Transporter 1 and Glutathione in Human Ovarian Cancer Cells.Involvement of PKCα and ERK1/2 signaling pathways in EGCG's protection against stress-induced neural injuries in Wistar rats.Flavonoids from Chinese bayberry leaves induced apoptosis and G1 cell cycle arrest via Erk pathway in ovarian cancer cells.Antiangiogenic Effect of Flavonoids and Chalcones: An Update.Development of a Time-Resolved Fluorescence Resonance Energy Transfer Ultrahigh-Throughput Screening Assay for Targeting the NSD3 and MYC Interaction.Dietary Compound Proanthocyanidins from Chinese bayberry (Myrica rubra Sieb. et Zucc.) leaves inhibit angiogenesis and regulate cell cycle of cisplatin-resistant ovarian cancer cells via targeting Akt pathway.Kaempferol Induces G2/M Cell Cycle Arrest via Checkpoint Kinase 2 and Promotes Apoptosis via Death Receptors in Human Ovarian Carcinoma A2780/CP70 Cells.Synergistic effect of black tea polyphenol, theaflavin-3,3'-digallate with cisplatin against cisplatin resistant human ovarian cancer cellsTheaflavins attenuate ethanol‑induced oxidative stress and cell apoptosis in gastric mucosa epithelial cells via downregulation of the mitogen‑activated protein kinase pathway
P2860
Q39615945-652EB72C-C76A-46E6-B9AC-2215AF3A03E5Q42378299-6C7C7429-B2ED-45B0-986A-12755D657A08Q45304689-9C1B4617-D9A5-4F0B-8376-D78FBD06C4C4Q46250945-558DB9F5-6665-4E16-B0CC-8F57F918023CQ47122646-AE7B8AA1-8ECA-46BC-92C9-817765A72F7DQ47232215-FE362C7D-1B03-4C6C-93D0-5D22E718EFFCQ48335155-68829C8E-C7EA-4B4A-B1A1-2B7310661758Q50038057-7D6E0851-B007-4D99-9A43-0CA18A280372Q50043004-71F78F6C-7A10-48E4-BC5B-4E02830F6FA2Q52596648-789623EE-A576-4748-B671-181EAC0DC8ACQ52724257-AE72758F-286C-48C0-8176-A4D5603D0DFBQ54111806-56D64266-BD07-4489-A05A-9C3C2BB00562Q58570585-5EE609AE-BE66-4222-8BA6-F43643F9654DQ58800904-774B869F-9665-4FB4-8E8A-CBC483DFE636
P2860
Theaflavin-3, 3'-digallate decreases human ovarian carcinoma OVCAR-3 cell-induced angiogenesis via Akt and Notch-1 pathways, not via MAPK pathways.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@ast
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@en
type
label
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@ast
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@en
prefLabel
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@ast
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@en
P2093
P2860
P356
P1476
Theaflavin-3, 3'-digallate dec ...... thways, not via MAPK pathways.
@en
P2093
Gary O Rankin
Yi Charlie Chen
Youying Tu
P2860
P304
P356
10.3892/IJO.2015.3257
P577
2015-11-20T00:00:00Z